Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Trikha

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Blood Advances|September 24, 2021
Defining the AHR-regulated transcriptome in NK cells reveals gene expression programs relevant to development and functionPrashant Trikha, Jena E Moseman, Aarohi Thakkar, et al.
Oncoimmunology|October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activatorPrashant Trikha, Robert L Plews, Andrew Stiff, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 RibonucleoproteinsMeisam Naeimi Kararoudi, Hamid Dolatshad, Prashant Trikha, et al.
Cancer Research|December 14, 2011
S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathwaysMohd W Nasser, Zahida Qamri, Yadwinder S Deol, et al.
Plos Genetics|October 3, 2007
CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cellsRene Opavsky, Shu-Huei Wang, Prashant Trikha, et al.
BMC Medical Genomics|October 17, 2015
Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12Amanda R Campbell, Kelly Regan, Neela Bhave, et al.
Nature|July 3, 2008
Mouse development with a single E2F activatorShih-Yin Tsai, Rene Opavsky, Nidhi Sharma, et al.
Genomics|October 12, 2004
A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignanciesLi Yu, Chunhui Liu, Kristi Bennett, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapySteven H Sun, Colin D Angell, Himanshu Savardekar, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Blood Advances|September 24, 2021
Defining the AHR-regulated transcriptome in NK cells reveals gene expression programs relevant to development and functionPrashant Trikha, Jena E Moseman, Aarohi Thakkar, et al.
Oncoimmunology|October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activatorPrashant Trikha, Robert L Plews, Andrew Stiff, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 RibonucleoproteinsMeisam Naeimi Kararoudi, Hamid Dolatshad, Prashant Trikha, et al.
Cancer Research|December 14, 2011
S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathwaysMohd W Nasser, Zahida Qamri, Yadwinder S Deol, et al.
Plos Genetics|October 3, 2007
CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cellsRene Opavsky, Shu-Huei Wang, Prashant Trikha, et al.
BMC Medical Genomics|October 17, 2015
Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12Amanda R Campbell, Kelly Regan, Neela Bhave, et al.
Nature|July 3, 2008
Mouse development with a single E2F activatorShih-Yin Tsai, Rene Opavsky, Nidhi Sharma, et al.
Genomics|October 12, 2004
A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignanciesLi Yu, Chunhui Liu, Kristi Bennett, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapySteven H Sun, Colin D Angell, Himanshu Savardekar, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Pageof 3